NIH-funded research R21 grant

Understanding brain lipid changes in aging and Lewy body dementia using advanced imaging techniques

Official title: Mapping Brain Lipid Architecture in Aging, LBD and T Cell Therapy using novel Imaging Mass Spectrometry

Funded at University of Florida · NIH-10991070 · Data updated 2026-11-12

This study is looking at how fats in the brain might affect the progression of Lewy body dementia and Parkinson's disease, using a special imaging technique to see where these fats are located, with the hope of finding new ways to help slow down these conditions.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$400,707
NIH project number1R21AG089638-01
Project IDNIH-10991070 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Lewy body dementia or Parkinson's disease, particularly those experiencing cognitive decline.

Less likely to help

Patients with other types of dementia or neurological disorders unrelated to Lewy body pathology may not benefit from this research.

What this research studies

This research investigates the role of lipids in the progression of Lewy body dementia (LBD) and Parkinson's disease (PD) by utilizing a novel imaging mass spectrometry technique. The study aims to visualize and quantify lipid distribution in the brain, which may provide insights into how these lipids contribute to neurodegeneration. By examining the lipid architecture over time, researchers hope to identify potential therapeutic targets and understand the underlying mechanisms of these diseases. Patients may benefit from this research through the development of new treatment strategies that could slow disease progression.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that slow the progression of Lewy body dementia and improve patient outcomes.

How similar studies have gone: Previous research has shown promising results in using lipid modulation as a therapeutic approach in neurodegenerative diseases, indicating potential for success in this novel application.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Vedam-Mai, Vinata — University of Florida
  • Study coordinator: Vedam-Mai, Vinata

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.